Lord Hunt of Kings Heath: My honourable friend the Parliamentary Under-Secretary for Work and Pensions (James Plaskitt) has made the following Written Ministerial Statement.
	The Employment, Social Policy, Health and Consumer Affairs Council was held on 1 June in Luxembourg. My honourable friend the Minister for Disabled People (Anne McGuire) represented the UK, except for the item on the working time directive, where the UK was represented by my right honourable friend the Secretary of State for Trade and Industry (Alistair Darling). Health and consumer affairs issues were taken on 2 June.
	There was a policy debate on the review of the EU sustainable development strategy. The presidency noted a consensus that there should be a synergy between work on social inclusion and poverty and the Lisbon agenda for growth and jobs. Child poverty and the global dimension were particularly important features. My honourable friend (Anne McGuire) stressed the importance of the agenda for growth and jobs. This offered the best route out of poverty, but we must be sure to give people the tools they need to take it and overcome poverty of ambition. She agreed with several ministerial colleagues that there was no need for a new process or elaborate new indicators.
	The Commission gave a presentation on its recent communication on social services of general interest and explained that the next stage is consultation with member states and stakeholders.
	The council reached agreement on a partial general approach on the first part of a new implementing regulation for 883/04 on social security for migrant workers. The UK maintained its parliamentary scrutiny reserve. A partial general approach was also agreed on amendments to annexe XI regulation 883/04.
	The council reached political agreement on a regulation establishing a European institute for gender equality. The Commission made a declaration to the minutes stating that it would have preferred a smaller administrative board. The UK lifted its parliamentary scrutiny reserve.
	The council adopted conclusions on women's health as part of the follow-up to the Beijing platform for action. The conclusions invite member states and the Commission to integrate gender health considerations into health policies with particular emphasis on the three indicators—healthy life years, access to health care (unmet demand) and cardiovascular diseases—proposed by the Austrian presidency.
	The joint contribution of the Employment Committee and the Social Protection Committee on the concept of "flexicurity" (balance between flexibility and security) was endorsed by the council.
	The presidency gave a progress report on the proposal for a directive on improving the portability of supplementary pension rights. A number of delegations intervened and my honourable friend (Anne McGuire) stated that there is a need to strike the right balance between mobility and maintaining the viability of pension provisions and supporting the view that there should be a broad application of any directive.
	The council reached political agreement on the amended proposal for a decision establishing a community programme for employment and social solidarity—PROGRESS. This is the EU-level spending programme for the period 2007 to 2013, which will provide financial support for the implementation of the Community's objectives for employment and social affairs and the achievement of Lisbon goals.
	The council reached political agreement without discussion on the annual employment guidelines on the proposal for a council decision on guidelines for the employment policies of the member states.
	My right honourable friend (Alistair Darling) represented the UK for discussions on the amended proposal for a directive concerning certain aspects of the organisation of working time. Negotiations revolved around the opt-out from the 48 hour working week. The presidency sought views at the lunchtime discussion on a presidency text. In the second session, it tabled a revised compromise proposal which was not agreed. The presidency introduced its final compromise in the final session, which many member states argued they could not support, some because the text did not phase out the opt-out and some, including the UK, that felt that proposals for restrictions and limitations on the opt-out went too far. The council failed to reach political agreement.
	The council received information from the presidency about a regulation on the Globalisation Adjustment Fund and about various presidency conferences. The council also received information on Commission communications on the posting of workers, corporate social responsibility, decent work and the European Year of Equal Opportunities in 2007.

Lord Warner: My right honourable friend the Secretary of State for Health has made the following Written Ministerial Statement.
	On 17 July 2003, my right honourable friend the Secretary of State for Trade and Industry announced the Government's response for England to the Office of Fair Trading (OFT) report, The control of entry regulations and retail pharmacy services in the UK (Official Report, Commons, cols. 76 to 79WS). This set out a balanced package of reform measures which we have introduced largely by amending secondary legislation effective from April 2005.
	Two remaining measures are in the Health Bill currently before Parliament. These are charging for pharmacy applications and including provision for NHS primary care trusts to take into account, when assessing competing applications, the improvements that they would bring to the provision of, or access to, over-the-counter medicines and other healthcare products and advice.
	The announcement in 2003 also committed the Government to review the progress made by these reforms in mid-2006 and to publish the findings. I have decided that the review should go ahead as promised. The terms of reference are to review and to report:
	progress in implementing the balanced package of reform measures introduced in England from April 2005 on the control of entry system for NHS pharmaceutical services;
	their effect on access to and the choice of NHS pharmaceutical services for patients, taking account of the new contractual framework in place since April 2005;
	their impact for consumers and the retail pharmacy market; and
	the extent to which the operation of the new regulatory system is proportionate to the aims and objectives of the reforms; and to publish the findings.
	The review will be led by Department of Health officials in conjunction with colleagues in the NHS and other government departments. The methodology will comprise:
	a quantitative analysis of NHS primary care trust (PCT) and other centrally sourced statistical data on community pharmacies, their applications to provide NHS services to PCTs, PCT decisions and appeals. This will also explore what discernible effect the reforms have had on pharmacy services in rural and socially deprived areas. It will be augmented as necessary by follow-up with PCTs;
	as a subset of this quantitative analysis, a further review of applications to PCTs and their decisions on pharmacies exempted since April 2005 from the control of entry requirements and their provision of NHS services;
	a comparative analysis of summary historical data on NHS dispensing by community pharmacies, openings and closures, distances between pharmacies and, where available, opening hours;
	taking account of the new contractual framework, a review of the extent of the reforms' economic impact to date, including discernible effects on services and their provision, competition, market structure, concentration and, if time series data are available for these, medicines-pricing strategies;
	a qualitative review of the reforms. Building on recent patient satisfaction consultations and surveys, the department will consult and invite PCTs, contractors, patients and consumer groups, health professionals and other interested parties to feed back views on the operation of the reformed procedures. This will examine: what impact there has been on access to services, particularly for those without transport or in more socially deprived areas; the quality of the services provided by community pharmacies following these reforms; how innovative they are; and developments that respondents may wish to see in future;
	a series of public regional "listening" events to complement the consultation and further meetings with representative bodies and other organisations as required to consider the impact of the reforms in more detail.
	I intend that the report should be completed and published by the end of October 2006. Further details of the consultation, which begins on Tuesday 13 June and ends on Tuesday 12 September, are available on the Department of Health's website at www.dh.gov.uk/PolicyAndGuidance/MedicinesPharmacyAndindustry/NHSPharmaceuticalRegulations/fs/en.
	Copies of the consultation document have been placed in the Library.